What are you looking for?
Nick Bruns, OD, FAAO, shares key insights on matching today’s intraocular lens options to each patient’s unique needs while recapping his American Optometric Association Meeting presentation. Nick Bruns, OD, FAAO: Hi, my name is Nick Bruns, [of] Summit Eye Care of Wisconsin. I just want to do a video recap of the lecture that we... ...
Jeff Banas, OD, FAAO, discusses his American Optometric Association Meeting presentation, highlighting the latest glaucoma technologies helping clinicians detect disease earlier and...
Low-dose atropine and Defocus Incorporated Multiple Segments (DIMS) lenses helped stabilize refractive development in preschool children at high familial risk for myopia,...
A 2-year interim analysis of the Myopia Atropine Dose (MAD) randomized clinical trial found modest axial elongation in children treated with atropine....
Nick Bruns, OD, FAAO, shares key insights on matching today’s intraocular lens options to each patient’s unique needs while recapping his American Optometric Association Meeting presentation. Nick Bruns, OD, FAAO:... ...
Jeff Banas, OD, FAAO, discusses his American Optometric Association Meeting presentation, highlighting the latest glaucoma technologies helping clinicians detect disease earlier and reduce patients’ dependence on eye drops. Jeff Banas,...
Low-dose atropine and Defocus Incorporated Multiple Segments (DIMS) lenses helped stabilize refractive development in preschool children at high familial risk for myopia, according to a study presented at the ARVO...
A 2-year interim analysis of the Myopia Atropine Dose (MAD) randomized clinical trial found modest axial elongation in children treated with atropine. The findings were presented in a poster at...
A case report presented at the Association of Cataract and Refractive Surgery (ASCRS) Annual Meeting highlights the successful management of severe keratoconjunctivitis sicca (KCS) and neurotrophic keratopathy (NK) secondary to autoimmune... ...
Patients with neurotrophic keratopathy (NK) frequently exhibit underlying autoimmune, dysimmune, and metabolic abnormalities, highlighting the potential role of systemic conditions in the disease and supporting the use of broader serological...
At SECO 2026, Katie Rachon, OD, of Virginia Eye Consultants, talks about a patient case that presented as dry eye disease but was actually stage 1 neurotrophic keratitis. She shared...
New subgroup analyses from the Phase 3 STAR trial presented at the 51st Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus show that SYD-101 0.01%, a low-dose...
An 84-year-old female with a history of cataracts and glaucoma was referred for evaluation and culturing of a corneal ulcer in the left eye extending into the visual axis. She...
At SECO 2026, Amanda Eslinger, OD, et al presented a complex case illustrating the diagnostic and management challenges of peripheral ulcerative keratitis (PUK) with concurrent neurotrophic keratitis (NK). The case...
Mark Dunbar, OD, of the Bascom Palmer Eye Institute, spoke with Optometry 360 about his presentation at SECO 2026. The study found that low-dose pilocarpine had minimal to no effect...
Sydnexis, Inc announced topline results from its Phase 3 STAR trial of SYD-101, a proprietary low-dose atropine formulation, showing significant reductions in myopia progression in children at AMCP Nexus 2025....
Pedram Hamrah, MD, of the University of South Florida, spoke with Optometry 360 at the AAO Annual Meeting 2025 about how the 2018 FDA approval of cenegermin for neurotrophic keratitis...